Abstract
Stress is a well-known risk factor to develop a functional neurological disorder, a frequent neuropsychiatric medical condition in which patients experience a variety of disabling neurological symptoms. Only little is known about biological stress regulation, and how it interacts with predisposing biological and psychosocial risk factors. Dysregulation of the hypothalamic–pituitary–adrenal axis in patients with functional neurological disorders has been postulated, but its relationship to preceding psychological trauma and brain anatomical changes remains to be elucidated. We set out to study the hypothalamic–pituitary–adrenal axis analysing the cortisol awakening response and diurnal baseline cortisol in 86 patients with mixed functional neurological symptoms compared to 76 healthy controls. We then examined the association between cortisol regulation and the severity and duration of traumatic life events. Finally, we analysed volumetric brain alterations in brain regions particularly sensitive to psychosocial stress, acting on the assumption of the neurotoxic effect of prolonged cortisol exposure.
Overall, patients had a significantly flatter cortisol awakening response (P < 0.001) and reported longer (P = 0.01) and more severe (P < 0.001) emotional neglect as compared to healthy controls. Moreover, volumes of the bilateral amygdala and hippocampus were found to be reduced in patients. Using a partial least squares correlation, we found that in patients, emotional neglect plays a role in the multivariate pattern between trauma history and hypothalamic–pituitary–adrenal axis dysfunction, while cortisol did not relate to reduced brain volumes. This suggests that psychological stress acts as a precipitating psychosocial risk factor, whereas a reduced brain volume rather represents a biological predisposing trait marker for the disorder. Contrarily, an inverse relationship between brain volume and cortisol was found in healthy controls, representing a potential neurotoxic effect of cortisol. These findings support the theory of reduced subcortical volumes representing a predisposing trait factor in functional neurological disorders, rather than a state effect of the illness. In summary, this study supports a stress–diathesis model for functional neurological disorders and showed an association between different attributes of trauma history and abnormalities in hypothalamus–pituitary–adrenal axis function. Moreover, we suggest that reduced hippocampal and amygdalar volumes represent a biological ‘trait marker’ for functional neurological disorder patients, which might contribute to a reduced resilience to stress.
Keywords: conversion disorders, emotional neglect, cortisol, hypothalamic–pituitary–adrenal axis, voxel-based morphometry, partial least squares correlation
Weber et al. provide evidence in support of a stress–diathesis model of functional neurological disorders. They identify trauma history in the form of emotional neglect as a psychological risk factor, and reduced hippocampus and amygdala volume as a predisposing biological trait marker.
Introduction
Functional neurological disorders (FNDs) represent a frequent medical condition1–3 in which typical symptom presentation,4,5 diagnostic criteria6 and multimodal treatment options1,3,7 are well established, but only little is known about the underlying neuropathophysiological mechanisms causing the diverse symptoms.8 Recent pathophysiological models focus on a multifactorial origin of FND in the framework of a stress–diathesis model9,10 (from the ancient Greek term ‘diathesis’ = predisposition) integrating predisposing, precipitating and preceding risk factors,3,11,12 and evaluate state versus trait markers of the disorder.13,14 Studying biopsychosocial vulnerability factors is thus of utmost importance and could further explain the development of FND symptoms in a subgroup of (biologically) vulnerable individuals with certain psychosocial risk factors.11,15
Negative life events have recurrently been reported in FND,12,16–18 traditionally highlighting the role of sexual and physical abuse during childhood as preceding risk factor.12,18,19 Moreover, severity and frequency of childhood abuse could be linked to symptom severity.20 Similarly, symptom onset and severity could be connected to recent adverse social-occupational life events with a partial link to early childhood physical and sexual abuse,19 highlighting the importance of type but also timing of trauma. In this regard, a recent meta-analysis confirmed an increased frequency of childhood and adult adverse life events and abuse in FND patients compared to healthy controls (HC) and psychiatric control patients.21 Additionally, emotional neglect was identified to be much stronger associated with the symptom development, and thus weakened the dominating role of sexual abuse in the suspected aetiology of FND.21
Neuroimaging studies intensively investigated the relationship between traumatic life events, symptom presentation and brain functional and structural abnormalities in FND. As such, structural alterations in limbic and motor regions could be associated with childhood abuse and symptom severity,22–24 whose effect was even more pronounced in women.25 Similarly, an aversive emotional stimulus-dependent alteration of cortico-limbic and limbic–motor brain networks, involving regions such as the hippocampus,26–28 the amygdala,28,29 the supplementary motor area (SMA)26 and the prefrontal cortex (PFC)26,27 have been identified in FND. Noteworthy, hippocampal deactivation is suggested to disinhibit the hypothalamus–pituitary–adrenal (HPA) axis, triggering a stress response,30,31 resulting in the release of stress hormones such as cortisol.32 HPA axis alterations—as observed, for example, under chronic stress—have been associated with neuroanatomical changes, particularly in the hippocampus, the amygdala or the PFC,33,34 which was attributed to a potential neurotoxic effect of glucocorticoids.33,35
In FND, some studies suggested that patients have prominent hyperarousal, as stress markers of the autonomic nervous system were found to be increased.36–38 Only few studies, however, analysed cortisol in FND36,39–43—as a measure of the adaptive (slow) stress response32—and the results were inconsistent. As such, decreased morning41 and basal diurnal43 cortisol were reported, in contrast to no differences42 or increased basal diurnal cortisol compared to levels in HC.39,40 This is explained essentially by methodological issues: studies were conducted using small sample sizes, focusing on only one particular symptom type, or within different test settings, potentially biasing the results.44 This highlights the need to study the role of biological stress in relation to its neurological and psychological correlates, which could advance the understanding of pathophysiological mechanisms in FND and could generalize previous findings.
We set out to study alterations in the HPA axis in a transdiagnostic approach across a large cohort of FND patients with mixed symptoms in a standardized domestic setting, to minimize biases of experimental setting. We adapted a transdiagnostic approach, as this efficiently targets the commonalities across the different symptom types. The primary aim was to assess the cortisol awakening response in FND compared to HC. The secondary aim was to evaluate the relationship between HPA axis dysfunction, volumetric brain alterations and preceding trauma, and to discuss their potential role as predisposing (trait) versus precipitating factors.
Materials and methods
Participants
The study was conducted at the University Hospital Inselspital Bern, Switzerland. We included data of 86 FND patients with motor (F44.4) and sensory symptoms (F44.6), with functional seizures (F44.5), mixed symptom type (F44.7) and persistent postural-perceptual dizziness (PPPD). Board-certified neurologists confirmed the diagnosis of FND according to DSM-56 and using positive signs.45 We included 76 age- and sex-matched HC. Due to coronavirus disease 2019 (COVID-19) pandemic regulations in the hospital, no HC older than 65 years were allowed to be invited, and thus FND patients older than 65 years were not matched. Exclusion criteria were: (i) major neurological comorbidities; (ii) a current severe psychiatric condition (acute suicidality, active psychotic symptoms); (iii) alcohol or drug abuse; (iv) pregnancy or breast-feeding; (v) contraindications for MRI; and (vi) insufficient language skills. The study was approved by the Competent Ethics Committee of the Canton Bern (SNCTP000002289) and conducted according to the Declaration of Helsinki. All subjects provided written informed consent.
Saliva samples
Saliva samples were collected according to the consensus guidelines of Stalder,44 concerning design and strategies to control for adherence, and to account for covariates. All participants were instructed in an initial face-to-face appointment and received written take-home instructions and a self-reported diary. We assessed smoking habits, and for female participants information about their menstrual cycle and intake of hormonal contraceptives, as they represent potentially confounding factors of cortisol secretion.44,46,47 Saliva was collected within a domestic setting and a sampling date convenient for the participant was set. A reminder was sent by e-mail the evening prior to the sampling date. Participants were asked to collect nine saliva samples throughout the day by chewing for 2 min on a cotton swab (Salivette Collection Devices, Sarstedt). Samples were taken directly upon awakening, at 15, 30, 45 and 60 min post awakening and further at 2, 3, 4 and 5 p.m. Participants were instructed to complete the five samples before breakfast and to refrain from heavy meals, fruits or fruit juices, coffee, carbonated soft drinks, chewing gum, smoking, teeth brushing or strenuous physical activities during the sampling in the morning and 45–60 min prior to sampling in the afternoon. Participants were instructed to note their wake up time, any deviations from the sampling time and potential confounds in their self-reported diary. Participants were free to wake up naturally or using an alarm clock and to follow their daily routine as usual. Saliva samples were collected the next day, centrifuged (10 min at 3900 rpm and room temperature) and frozen at −20°C.
Demographic, behavioural and clinical characteristics
Symptom severity was evaluated using the Clinical Global Impression (CGI) score (0 = no symptoms to 7 = among the most extremely ill patients) and the Simplified Version of the Functional Movement Disorder Rating Scale (S-FMDRS)48. Duration of symptoms was calculated from onset of symptoms to date of the study inclusion (in months). Use of psychotropic medication (i.e. benzodiazepines, opioids, antidepressants, neuroleptics and antiepileptics) as well as corticosteroid medication were recorded. Mood was assessed using the Spielberg State–Trait Anxiety Inventory (STAI)49 and Beck’s Depression Inventory (BDI)50. Sleep quality of the night prior to saliva sampling was assessed using items four and five of the Leeds Sleep Evaluation Questionnaire (LSEQ)51.
Traumatic life events
Traumatic life experiences were measured using the Traumatic Experiences Checklist (TEC)52. The TEC is a 29-item self-reported questionnaire that assesses the presence of diverse physical, emotional and sexual traumata including age, relationship to the perpetrator and the self-reported impact of the respective trauma. The TEC was scored using the syntax available at https://www.dissociativedisorder.org/elibrary-english. Based on the syntax we computed (i) the overall number of experienced traumata (sum of all items); (ii) six individual trauma severity subscores (determined by subjective impact and age of trauma for emotional neglect, emotional abuse, physical abuse, sexual harassment, sexual abuse and bodily threat); and (iii) developmental composite scores calculating experienced trauma according to the age ranges of 0–6 years, 7–12 years, 13–18 years and >19 years. Additionally, we computed duration and relationship to the perpetrator for each trauma subscore. The duration of trauma was calculated using the maximum duration within those questions belonging to each trauma subscore. The relationship to the perpetrator was coded into categorical variables being one: inner family circle (parents, siblings, partner), two: outer family circle (relatives), three: friends and acquaintances, four: strangers. Additionally, to focus on trauma occurring only during childhood, we used the Childhood Trauma Questionnaire (CTQ),53 a 25-item self-reported questionnaire which assesses childhood trauma across five domains including emotional and physical abuse and neglect and sexual abuse.
Saliva samples analysis
Salivary cortisol was analysed by a commercial saliva-specific competitive enzyme immunoassay (cELISA, Salimetrics). The manufacturer states a functional sensitivity of 0.28 ng/ml and cross-reactivity for 14 endogenous and synthetic steroids is reported to be <1% each. The assay had been used according to the manufacturer’s protocol. Intra- and inter-assay coefficients of variation were 4.5% and 4.8%, respectively.
Neuroimaging data acquisition and pre-processing
To investigate neuroanatomical differences between patients and controls, we used a voxel-based morphometry approach. Anatomical images were acquired for all subjects except of three FND patients and three HC. MRI sequence and pre-processing is detailed in the Supplementary material.
Statistical analysis
Behavioural data
Statistical analyses were performed using R software (version 4.1.2.) and MATLAB (R2017b, MathWorks Inc., Natick, USA). Questionnaire data were tested for normality using Shapiro–Wilk’s test. Normally distributed data were analysed using two-sample t-test, highly skewed data using Wilcoxon rank sum test. Questionnaires with subscores were corrected for multiple comparisons using FDR. Categorical data were analysed using chi-squared test (sex) and Fisher’s exact test [menstrual cycle and relationship to perpetrator (TEC)]. To determine significance, alpha-level was set at P < 0.05.
Biological data
We analysed two metrics to assess cortisol levels: the cortisol awakening response (CAR) and the diurnal baseline cortisol (DBC).
The CAR describes the rapid increase in cortisol secretion across the first 30–45 min upon awakening and, thus, represents the dynamic changes of cortisol secretion occurring upon awakening.44,54 It has been shown that the intraindividual stability is relatively high and subtle changes in HPA axis function regarding environmental noise can be detected with high accuracy.47 To assess group cortisol differences in the CAR, a repeated-measures ANOVA was used on the fitted data of the five morning samples (wake-up until 60 min post-awakening) using a linear mixed model with fixed effects of factor group and time point, and using age, sex, smoking, wake up time, BDI, STAI, hormonal contraception, corticosteroid medication, psychotropic medication, menstrual cycle, menopause and sleep quality as covariates of no interest.46
The DBC represents the dynamic changes of cortisol throughout the afternoon (from 2 p.m. to 5 p.m.). To analyse the DBC, the same analysis was performed as in the CAR using the four samples in the afternoon. For the analyses of the CAR and the DBC, we excluded data from eight FND patients and nine HC as they did not properly adhere to the saliva sampling protocol with either missing samples (n = 3) and/or delays (n = 16) (strict sampling accuracy margin of Δt > 5 min for post-awakening samples and Δt > 15 min for afternoon samples44).
As we were interested in examining the multivariate pattern of correlation between cortisol and other variables (see below), single estimates of the CAR and the DBC were calculated using area under the curve (AUC)-based measures, as recommended in methodological consensus guidelines.44,55 As such, the post-awakening cortisol concentration (PACC) and the diurnal baseline cortisol concentration (DBCC) were computed. The PACC describes the summed cortisol concentration across the first five samples in the morning. The DBCC represents the cumulative cortisol concentration of the four afternoon samples. As a measure for the PACC and DBCC, the AUC with respect to ground (AUCG) was calculated. Additionally, as a (static) measure for the CAR, the AUC with respect to increase (AUCI) was calculated on the five morning samples (CARi).44 AUC-based measures were calculated according to Pruessner.54 Three subjects were excluded for calculating the AUC-based measures due to missing samples. Subjects reporting delays were included, as the AUC formula can account for sampling delays (see Supplementary material and Supplementary Fig. 1 for more details). All analyses were repeated in females only Supplementary Fig. 9.
Imaging data
To analyse between-group differences of cortical volumes, we first applied a general linear model on the smoothed whole-brain anatomical images within SPM12. Second, given the a priori hypothesis of the hippocampus and the amygdala being particularly vulnerable to anatomical changes in the context of chronic stress,33,34 we analysed volumetric differences in those two regions. As such, we performed two region-of-interest analyses using the corresponding region-of-interest masks, derived from the automatic anatomic labelling atlas 3 (AAL3)56. Whole-brain as well as region-of-interest analyses were corrected for multiple comparisons using a family-wise error (FWE) rate at P < 0.05, and total intracranial volume (TIV), age, sex, depression and anxiety were added to the analysis as covariates of no interest. Lastly, we extracted subject-wise estimates of the mean region-of-interest volumes for external analyses. All analyses were repeated in females only Supplementary Fig. 10 and Supplementary Table 6.
Multivariate pattern of correlation
In a last step, we applied partial least squares correlation (PLSC)57,58 to evaluate multivariate patterns of correlation between behavioural data (trauma scores), cortisol AUCG and AUCI measures (CARi, PACC, DBCC), and volumetric data (mean region-of-interest volume) in FND patients and healthy controls. For the PLSC analysis, only those subjects were included for whom salivary cortisol (FND = 84, HC = 75) and imaging data (FND = 83, HC = 73) were complete. Data were standardized and a correlation matrix was calculated between the two sets of variables. To find individual weights of the corresponding data tables (cortisol data, volumetric data, trauma scores), a single value decomposition (SVD) was applied on the correlation matrix. The SVD leads to different correlation components consisting of a set of design weights and outcome weights (saliences), indicating the strength of contribution of each weight to the multivariate pattern. The weights were used to calculate two sets of latent variables as such that the covariance was maximized. Significance was evaluated by permutation testing (5000 permutations). Stability of the weights was assessed using bootstrapping (200 bootstrapping samples). PLSC allows for examining the relationship between multiple variables with different attributes. We used the publicly available PLS toolbox for MATLAB (https://github.com/FND-ResearchGroup/myPLS_SL.git), the use of which has already been described in other studies.59,60
We conducted three individual PLSC analyses. First, we used the cortisol values as design variables and TEC severity scores, developmental scores, duration of trauma and relationship to the perpetrator as outcome variables to evaluate multivariate pattern of correlation of trauma history and HPA axis dysfunction. Second, we used the volumetric data of the whole-brain, as well as hippocampus and the amygdala alone (normalized for TIVs) as design variables, and age, sex and cortisol values as outcome variables to evaluate the multivariate pattern of correlation between cortisol and changes in brain volume. Lastly, we evaluated in patients only the relationship of the aforementioned factors with clinical data (i.e. symptom severity and duration of symptoms) (Supplementary Figs 6–8).
Data availability
The data are not publicly available due to restrictions demanded by the administering institution to guarantee the privacy of the participants. The data can be shared upon request.
Results
Clinical, behavioural and demographic characteristics
Data from 86 FND patients and 76 age- and sex-matched HC were included in this study. Demographic, behavioural and clinical data are presented in Table 1. The most common symptom types were sensorimotor deficit (38.7%), gait disorder (21.5%) and/or tremor (14.6%). Level of diagnostic certainty for functional seizure patients were: seven probable, three clinically established and four documented, according to diagnostic criteria of LaFrance.61 Five patients were currently under corticosteroid medication, four of them only in a topical form (nasal spray) used irregularly on demand, and one patient was under oral prednisone medication. Patients using sprays resigned from using them on the day of saliva collection. FND patients and HC significantly differed in their smoking habits (more smokers in FND), their BDI and STAI scores (more depression and anxiety in FND).
Table 1.
Demographic, behavioural and clinical data
| FND (n = 86) | HC (n = 76) | Statistics | |
|---|---|---|---|
| Age, years, mean (SD), [range] | 37.7 (14.2), [17–77] | 33.1 (10.9), [18–62] | ns |
| Sex, females/males | 64/22 | 55/21 | ns |
| ȃHormonal contraception, yes/no | 27/37 | 18/37 | ns |
| ȃMenopause, yes/no | 14/50 | 10/45 | ns |
| ȃMenstrual cyclea | 15 anovulation 10 follicular 22 luteal 2 menstruation 7 ovulation |
10 anovulation 3 follicular 33 luteal 1 menstruation 3 ovulation |
Two-tailed *P = 0.05 |
| Smoker, yes/no | 33/53 | 8/68 | χ2(1) = 15.2, ***P < 0.0009 |
| Disease severity (CGI) median [quantile] | 2 [1–4] | NA | – |
| Disease severity (S-FMDRS) median [quantile] | 6 [2–12.75] | NA | – |
| Duration of illness, months | 75 (166) | – | – |
| Symptom typeb | 45 sensorimotor 25 gait disorder 17 tremor 12 myoclonus 14 seizures 8 dystonia 7 PPPD 5 speech disorder 2 functional deafness 1 functional vision loss |
NA | – |
| ICD-10 classificationc | 63 F44.4 7 F44.5 30 F44.6 8 F44.7 6 PPPD |
NA | – |
| Psychotropic medication | 14 benzodiazepines 29 antidepressants 6 neuroleptics 9 antiepileptics 6 opioids |
0/76 | – |
| Corticosteroids, yes/no | 5/81 | 0/76 | – |
| BDI score, mean (SD) | 14.4 (9.96) | 4.59 (6.28) | Z = −7.61, ***P < 0.0001 |
| STAI-S score, mean (SD) | 37.2 (10.9) | 32.1 (7.67) | t(156.68) = 3.22, **P = 0.002 |
| LSEQ, mean (SD) | 0.422 (0.169) | 0.455 (0.15) | ns |
ns = not significant; SD = standard deviation. ***P < 0.001, **P < 0.01, *P < 0.05.
Menstrual cycle was indeterminable in eight patients and five healthy controls (natural irregularity or continuous intake of hormonal contraception).
Patients can present with several symptom types.
Diagnosis of mixed FND (F44.7) was given when F44.4, F44.5 and F44.6 was present.
Trauma
Traumatic life events
Overall number of experienced traumata (TEC): FND patients experienced significantly more total traumatic events compared to HC [reported as mean ± standard deviation (SD): FND 6.78 ± 4.37, HC 4.21 ± 4.22, Z = 4541, P < 0.001; Fig. 1A].
Trauma severity scores (TEC): FND patients reported significantly more emotional neglect (FND 5.26 ± 6.32 versus HC 2.4 ± 4.68, Z = 4247, P = 0.002; Fig. 1B).
Developmental composite scores (TEC): FND patients reported significantly more traumata occurring in the age range from 0 to 6 (FND 3.43 ± 4.87 versus HC 2.08 ± 3.93, Z = 3810, P = 0.43) from 7 to 12 (FND 4.71 ± 4.81 versus HC 3.07 ± 4.17, Z = 3962, P = 0.043) and >19 years old (FND 2.9 ± 4.03 versus HC 1.26 ± 2.24, Z = 3840, P = 0.01) (Fig. 1C).
Duration of trauma (TEC): FND patients reported a longer duration of emotional neglect as compared to HC, i.e. 4.5 years longer (FND 6.95 ± 1.2 years versus HC 2.36 ± 0.6 years, Z = 3984, P = 0.01; Fig. 1D). No significant differences were found with respect to duration of trauma for the other subscores.
Relationship to the perpetrator (TEC): in FND patients, emotional neglect occurred more often through members of the inner family circle (two-sided, P = 0.006). No significant differences were found in the other subscores.
Figure 1.
Traumatic life events. (A) For visualization purposes, means and confidence intervals of overall number of experienced traumata (ranging from 0 to 29). (B) Means and confidence intervals of six trauma severity scores (determined by subjective impact and age of trauma, ranging from 0 to 13 for emotional neglect, emotional abuse, physical abuse, sexual harassment and sexual abuse or from 0 to 24 for bodily threat). (C) Means and confidence intervals of developmental composite scores (across trauma subscores). (D) Means and confidence intervals of duration of trauma. ***P < 0.001, **P < 0.01, *P < 0.05. Results are FDR-corrected.
Childhood trauma
FND patients reported significantly more childhood emotional abuse (CTQ scale reported as mean ± SD: FND 10.1 ± 5.1, HC 8.2 ± 4.2, Z = 4028, P = 0.02), emotional neglect (FND 11.1 ± 5.1, HC 8.8 ± 4.2, Z = 4194, P = 0.009), physical abuse (FND 7.3 ± 4.0, HC 5.9 ± 2.0, Z = 3875, P = 0.03) and physical neglect (FND 7.7 ± 3.1, HC 6.79 ± 2.83, Z = 3935, P = 0.03) (Supplementary Fig. 2).
Salivary cortisol
A significant main effect of group was found for the CAR [F(1,680) = 28.81, P < 0.0001] with lower levels in FND than HC. Post hoc multiple comparisons between group and time points showed that FND patients and HC significantly different in their cortisol levels at time points 30 min upon awakening, and almost reached significance at time point 15, 45, and 60 min upon awakening (P = 0.052) (Fig. 2). No significant differences were found in the DBC.
Figure 2.
Cortisol profile of FND patients and healthy controls. Mean and confidence intervals of daytime cortisol profile in FND patients and HC. *P < 0.05.
Volumetric brain alterations in patients with functional neurological disorders
On a whole-brain level, significant group differences were found between FND patients and HC in five clusters at thresholds of PFWE = 0.05 (Fig. 3A and Table 2). These clusters included the following regions with decreased volumes in FND compared to controls: left superior temporal gyrus, left gyrus rectus, bilateral amygdala, hippocampal and parahippocampal gyri, as well as dorsolateral prefrontal gyri.
Figure 3.
Results of voxel-based morphometry analysis. (A) Differential effect of voxel-wise comparison (HC > FND) with smaller grey-matter volume in FND in the hippocampus, parahippocampal gyri, amygdala and dorsolateral frontal gyri. (B) Differential effect of mean region-of-interest volume using a hippocampal mask (upper panel) and amygdala mask (lower panel) with smaller grey-matter volume in FND. For both analyses, total intracranial volume (TIV), age, sex, depression (BDI) and anxiety (STAI) were added as covariates, thresholded on whole-brain level at PFWE < 0.05. ***P < 0.001, **P < 0.01, *P < 0.05. A model corrected only for TIV, age and sex can be found in Supplementary Fig. 3 and Supplementary Table 3.
Table 2.
Whole-brain voxel-based morphometric results with TIV, age, sex, depression (BDI) and anxiety (STAI) as covariates of no interest
| Cluster level | Peak level | Peak coordinates in MNI space {mm} | Cerebral regions | ||||||
|---|---|---|---|---|---|---|---|---|---|
| P FWE | P FDR | Cluster extent | P FWE | P FDR | Peak voxel Z-score | x | y | z | |
| 0.001 | 0.084 | 255 | 0.002 | 0.506 | 5.248 | −54 | −27 | 14 | Left superior temporal gyrus |
| 0.000 | 0.004 | 633 | 0.004 | 0.506 | 5.122 | −15 | 3 | −24 | Left parahippocampal |
| 0.006 | 0.667 | 4.996 | −23 | −1.5 | −18 | Left amygdala | |||
| 0.017 | 0.875 | 4.783 | −29 | −17 | −14 | Left hippocampus | |||
| 0.006 | 0.553 | 82 | 0.004 | 0.506 | 5.117 | 0 | 62 | −26 | Left gyrus rectus |
| 0.008 | 0.553 | 69 | 0.014 | 0.875 | 4.831 | 15 | 3 | −24 | Right parahippocampal |
| 0.035 | 0.917 | 4.607 | 17 | −6 | −15 | Right amygdala | |||
| 0.009 | 0.553 | 61 | 0.019 | 0.875 | 4.753 | −11 | 59 | −15 | Left superior frontal gyrus |
| 0.026 | 0.897 | 4.680 | −6 | 59 | −7.5 | Left dorsolateral prefrontal gyrus | |||
In line with the results on a whole-brain level, we confirmed our a priori hypothesis of a reduced hippocampal and amygdalar volume in FND patients using an inclusive brain mask at thresholds of PFWE = 0.05 (Fig. 3B and Supplementary Tables 1 and 2). Upon extraction of region-of-interest volumes for external analyses, we found that the hippocampus as well as amygdala volume were significantly smaller in FND patients compared to HC [F(1,614) = 102, P < 0.001]. Post hoc Tukey’s HSD test revealed a significant difference between FND patients and HC in (i) the left hippocampus (P < 0.001); (ii) the right hippocampus (P < 0.001; Fig. 3A, upper panel); (iii) the left amygdala (P = 0.016); and (iv) the right amygdala (P = 0.025; Fig. 3B, lower panel).
Relationship between trauma and cortisol
To evaluate relevance of experienced trauma on the single estimates of the cortisol measures (CARi, PACC and DBCC) in FND patients and HC, we first conducted a behavioural PLSC including TEC severity scores, developmental scores, duration of trauma and relationship to the perpetrator as outcome variables. One PLSC component was found to be statistically significant based on the permutation testing (P = 0.033). The outcome and cortisol saliences of the previously mentioned component are shown in Fig. 4. Yellow highlighted weights indicate that they were found to be robust (with the green dots representing the cortisol salience weights) and can be interpreted similarly to correlation coefficients as the data were standardized. Based on the PLSC results, a significant positive correlation was found in patients between the morning cortisol values (CARi, PACC) and the relationship to the perpetrator of physical abuse—meaning that the more familiar (inner family circle) the perpetrator was, the higher the cortisol values. A significant negative correlation was found in patients between the morning cortisol values (CARi, PACC) and (i) the duration and (ii) the severity of emotional neglect—meaning that the longer and more severe the emotional neglect, the lower the cortisol values. In HC, a positive correlation was found between cortisol values and (i) trauma occurring during late adolescence and (ii) adulthood—meaning that the more trauma happened during late adolescence and adulthood, the higher the cortisol levels.
Figure 4.
PLSC results of the different cortisol measures (CARi, PACC, DBCC) in FND patients and healthy controls. The outcome (A) and cortisol saliences (B) of the significant PLSC component (P = 0.033) are presented. Fifth to 95th percentiles of bootstrapping are indicated in the error bars and highlighted bars indicate robustness. The height of the bar corresponds to the salience weight to the multivariate correlation pattern and can be interpreted similarly to correlation coefficients as the data were standardized. The permutation null distribution and the bootstrap mean percentiles are reported in Supplementary Fig. 4 and Supplementary Table 4. EN = emotional neglect; EA = emotional abuse; PA = physical abuse; SH = sexual harassment; SA = sexual abuse; BT = bodily threat.
Relationship between cortisol and brain volume
To examine the potential relationship between single estimates of the cortisol measures (CARi, PACC and DBCC) and changes in whole brain, respectively, hippocampal and amygdalar volumes in FND patients and HC, we conducted a PLSC including cortisol values as outcome variables and imaging data as design variables. No significant PLSC components were found when using the mean cluster volumes from the whole-brain analysis as design variables. When using the results from our region-of-interest analysis (i.e. hippocampal and amygdalar volume), one PLSC component was found to be statistically significant (permutation testing, P = 0.021). The outcome and imaging saliences are shown in Fig. 5.
Figure 5.
PLSC results of the imaging data (hippocampal and amygdalar volumes) in FND patients and healthy controls. The outcome (A) and imaging saliences (B) of the significant PLSC component (P = 0.021) are presented. Fifth to 95th percentiles of bootstrapping are indicated in the error bars and highlighted bars indicate robustness. The height of the bar corresponds to the salience weight to the multivariate correlation pattern and can be interpreted similarly to correlation coefficients as the data were standardized. The permutation null distribution and the bootstrap mean percentiles are reported in Supplementary Fig. 5 and Supplementary Table 5.
Based on this PLSC analysis, a significant negative correlation was found only in HC between the brain volumes of the bilateral hippocampus and the bilateral amygdala and (i) the age, meaning that the older the subject, the smaller the brain volume; and (ii) CARi, meaning the smaller the brain volume, the higher the cortisol levels. No multivariate pattern of correlation between brain volumes and cortisol data was found in FND patients.
Relationship with symptom severity in functional neurological disorders
No significant multivariate correlation was identified in patients, when using symptom severity as outcome variable, and trauma scores, single estimates of cortisol measures or brain volumes, independently, as design variables (Supplementary Figs 6–8).
Discussion
Our findings provide biopsychological evidence for the stress–diathesis model in FND (state versus trait). We identified a reduced cortisol awakening response in a transdiagnostic approach in FND patients. Moreover, we linked the potential HPA axis dysregulation to prolonged preceding emotional neglect, pointing towards a long-term process resulting in a maladaptive HPA axis sensitization. Lastly, we identified anatomical changes in the superior frontal gyrus, the superior temporal gyrus, the hippocampus and the amygdala. In FND, however, reduced cortical volumes were not associated with cortisol, whichwould have pointed towards a potential neurotoxic effect, nor with symptom severity, which could have explained a state-related change. These findings put in question whether the results found here represent a direct state effect of FND, a biological trait factor or a combination of both, as will be further discussed below. A schematic representation of the results discussed here is displayed in Fig. 6.
Figure 6.
The stress–diathesis model in functional neurological disorders. The aetiology of FND is multifactorial and depends on predisposing, precipitating, and perpetuating risk factors. Long-term exposure to stress can exert neurotoxic effects on regions particularly sensitive to cortisol. Moreover, it can alter the HPA axis in terms of a maladaptive habituation. Distinct predisposing factors, i.e. ‘trait’ markers might influence the individual resilience to stress and the later development of psychopathology. CRF = corticotropin-releasing factor; ACTH = adrenocorticotropic hormone.
Only few studies investigated cortisol levels and the stress response in FND patients. Consistent with our results, Chung et al.41 detected a blunted CAR in 32 children with FND (mixed symptoms) assessed using two saliva samples in the morning (at wake up and 30 min later), which were partially collected in a domestic setting. Likewise, a study in 15 female functional seizure patients identified lower serum cortisol levels in the morning as compared to HC with a history of abuse.43 Contradictorily, in a study in which 33 motor FND patients and 33 HC were hospitalized overnight, no difference in morning cortisol levels were found.42 This discordance might be explained by the testing conditions: a non-familiar environment (e.g. hospitalization42) might introduce alterations in cortisol levels that covary with psychosocial factors and might not represent the clinical status of patients.44,62 Consistent with our results, no group differences in the basal diurnal cortisol levels were found in 19 functional seizure patients,36 or in motor FND patients (n = 16,39n = 3342). Contrarily, a group effect with higher basal diurnal cortisol levels in the afternoon was found in motor FND,39 mainly driven by stress, as well as in functional seizure patients,40 mainly driven by experienced sexual abuse. Lastly, cortisol secretion was studied in response to stress. Using the Trier Social Stress Test, two studies reported a comparable stress response in FND patients as to HC indicating a normal adaptation to social stress situations.36,39 In summary, previous results on cortisol in FND show a large heterogeneity, mainly explained by methodological issues: each of the studies was conducted in a different setting (stress test36,39,40versus no stress test and domestic setting versus hospitalized41–43), assessing different measures of cortisol (i.e. morning versus basal versus stress response), which in most cases prevents a direct comparison between results. Our transdiagnostic approach has the advantage of having a large sample with mixed symptoms, which ensures a better generalizability in comparison to previous studies focused on small subgroups of FND patients.
Additionally, and firstly in FND, we identified an inverse relationship between cortisol measures and various dimensions of emotional neglect (assessed using the TEC), whereas no association with symptom severity or duration of symptoms was detected. As such, a significant multivariate pattern of correlation was found in patients but not in controls, between lower morning cortisol levels and higher duration and severity scores of emotional neglect (measured by the TEC). Specifically for emotional neglect, exposure was on average 4.5 years longer in FND as compared to HC. In general, adverse experiences occurred more frequent in early childhood in FND than in HC, even though this effect was not specific to emotional neglect but was found across all traumatic experiences. This result is consistent with the findings on the CTQ, in which increased neglect and abuse was found in FND across all trauma subscores except for sexual abuse. In particular, the role of neglect as a predisposing factor of FND has been highlighted by the results of a meta-analysis of 34 case–control studies including 1405 patients showing ORs of 5.6 for FND patients compared to control populations, which was higher than for sexual and physical abuse (odds ratio 3.3 and 3.9, respectively).21 Our results go further than confirming an association between emotional neglect and FND in demonstrating that both the severity and duration of emotional neglect are more pronounced in FND. The effect of maltreatment on different expressions of psychopathology has been shown to depend on the developmental period, severity and frequency of trauma exposure.63,64 In FND, no clear consensus on the role of trauma type, timing and number of traumatic events is known, with the exception that early-onset FND was rather associated to childhood sexual abuse65 when late-onset was associated to physical trauma.66 In summary, our results add to previous knowledge that trauma predisposes to FND, highlighting the importance of emotional neglect. Additionally, we first showed that in FND, exposure to early and long-lasting emotional neglect might contribute to disrupting the biological regulation of stress, as reflected by the association with blunted CAR. This is further supported by the absence of an association between CAR and symptom severity, as an association between CAR and symptom severity would rather indicate a (subacute) disease-related (‘state’) change of the HPA axis.
Thereby, dysregulation of morning cortisol secretion might represent a downregulation of the HPA axis following initial high levels of cortisol in response to long-term stress.67 A proposed mechanism of action is the suppression of the negative feedback inhibition of cortisol.33,34 Under normal health conditions, an acute stressor would activate the HPA axis and subsequent cortisol secretion through the amygdala. The amygdala is strongly regulated by the PFC and the hippocampus, which are responsible for the integration of information on threat stimuli. When the stressor is removed, a negative feedback inhibition is induced through the hippocampus and the HPA axis itself, reducing the cortisol secretion. In a chronic state of hypervigilance to stressors, the HPA axis is tonically inhibited through the hippocampus, as a result of suppressed negative feedback inhibition due to HPA axis sensitization (maladaptive habituation) to the stressor. Correspondingly, an overreactive HPA axis has been observed in early phases of chronic stress, whereas a downregulation corresponds to subsequent, sustained phases of chronic stress.68 Hence, the prolonged exposure to emotional neglect in FND patients might reflect a long-term process resulting in the downregulation of the HPA axis, as represented in the flattened CAR. At the same time, it is suspected that glucocorticoid receptors become more sensitive to enhanced cortisol levels during early phases of chronic stress, and consequently to the increased neurotoxic effects of cortisol.69–71 Chronic stress indeed has been repeatedly associated with neuroanatomic alterations in regions expressing a high glucocorticoid receptors density, i.e. hippocampus, PFC and amygdala (for review see Lupien et al.33 and McEwan34). In FND, a volume reduction of the hippocampus has previously been found to inversely relate to trauma history.25 No data on cortisol were available in this study, but it was hypothesized that the hippocampal atrophy might be mediated by changes in stress biomarkers such as cortisol. However, large variation in hippocampal volumes has also been described in healthy populations, irrespective of chronic stress or trauma history, suggesting that reduced hippocampal volume may represent a trait factor rather than a disease-related feature (state).72 In line with these findings, our results on smaller hippocampal and amygdalar volumes compared to HC, and the absence of a correlation with cortisol measures or with symptom severity suggest that these anatomical variations rather represent a trait factor for FND, in terms of a biological predisposition. Interestingly, while some studies neither identified a relationship between cortical volumes and symptom severity,23,73,74 recent studies inversely correlated symptom severity to lower volumes in regions other than the hippocampus, such as the left insula,22,25,75 precentral gyrus,75 as well as the temporo-parietal junction.76 Therefore, regional differences in cortical volume might be linked to trait vulnerability (e.g. hippocampus) while others might be linked to disorder-related pathophysiological changes (state). However, additional research is needed to disentangle the role of regional structural abnormalities in the pathophysiology of FND. On the contrary, in HC the inverse relationship between subcortical volume and cortisol measures may represent a plasticity phenomenon in response to recent stress. In summary, a disease model including HPA axis sensitization might contribute to the development of FND in terms of maladapting to long-term emotional neglect. Moreover, the reduced hippocampal and amygdalar volumes in FND found here point towards a ‘trait’ biomarker for FND, which potentially decreases the resilience to stress.
Psychosocial stressors, HPA axis sensitization and biological predisposition might represent transdiagnostic risk factors,77 which conjointly contribute to general psychopathology and symptom overlaps in neuropsychiatric disorders.78 However, by way of example, about 15% of childhood maltreatment survivors do not develop mental health problems79 and further variations in psychopathology have been explained by individual resilience to stress.78 Similarly, FND represents a disorder of multifactorial origin.3 Biopsychological risk factors might interplay with other, yet unknown factors which might explain why a subgroup of vulnerable individuals develop FND and not any other psychopathology. Recently, research on resilience focuses not only on the exploration of eco-phenotypes (i.e. environmental factors), but also genetics and their interplay (endo-phenotypes, i.e. gene × environment interactions). As such, early life adversities may influence brain development and mental health outcome by means of (epi-) genetic mechanisms. The first two years of development is the critical window for emotional development and has been associated with increased risk for mental disorders and negative impact on the brain structure and function.80,81 Emotional neglect during early childhood is often accompanied by social disentanglement and rejection, which prevents children learning how to properly process emotions,82–84 as found in FND populations.26,85–87 In terms of gene × environment interactions, a genetic variation in the oxytocin receptor (OXTR) in subjects with a history of childhood emotional neglect was associated with reduced amygdalar and hippocampal brain volumes.88 The role of oxytocin in emotion processing has been studied in infants (5–7 months old): infants with increased OXTR methylation rates showed enhanced response to aversive faces in a functional neuroimaging paradigm.89 Epigenetic changes in the oxytocin pathway are as well of particular interest in FND, as increased OXTR methylation was demonstrated in a cohort of 16 FND patients compared to 15 HC.90 Other genetic/epigenetic changes in FND have been very recently studied: Diez et al.28 linked history of childhood physical abuse to cortico-limbic brain network dysfunction in regions which in situ showed an overlap with high expression of genes involved in neuronal morphogenesis. Those findings firstly linked childhood trauma and its potential effects on brain function to a trauma-related functional brain reorganization in the context of a gene × environment interaction in FND. In the same line of research, tryptophan-hydroxylase 2 (THP2) polymorphism was associated with childhood trauma, symptom onset and severity, as well as amygdalar functional connectivity in FND.91 In summary, individual resilience factors might explain how early childhood emotional neglect potentially induce (epigenetically mediated) neurodevelopmental delays in individuals who later develop FND affecting brain structure and function of regions involved in emotion regulation, which is reflected in a dysfunctional HPA axis. Further research must be conducted to identify risk factors specific for FND.
Our study has several limitations. First, the measure of cortisol awakening response relies on self-reported diaries and deviations from the protocol cannot be fully controlled. To verify accurate execution of cortisol sampling, objective verification of awakening and sampling times are required,92 e.g. using objective electronic monitoring systems, such as polysomnography or wrist actigraphy.93 We did not use such objective tools but minimized the risk of error of self-report data by thoroughly instructing our participants, agreeing on an appropriate day for the sampling, and explaining the importance of properly adhering to the protocol and/or reporting deviations from the protocol. Second, we collected saliva samples on only one day, thus cortisol alterations might represent fluctuations due to situational aspects rather than a long-term trait.44 Thirdly, salivary cortisol only indirectly measures HPA axis activity, as it depends on levels of other biological factors such as corticotropin-releasing factor, adrenocorticotropic hormone or oestrogens.94 Nonetheless, salivary cortisol is considered to be a good measure of allostatic load and a useful biomarker in stress research.47,94 Another limitation in studying the role of trauma lies in methodological issues as self-report questionnaires can have recall bias.21 Detailed interview techniques95 are less prone to recall bias but are time-consuming and require appropriate training of study personnel, which limits their feasibility in larger cohorts of participants. Lastly, our patient cohort has only been compared to HC, which prevents making conclusions on the specificity of the findings to FND in comparison to other stress-related disorders. However, we corrected for depression and anxiety and excluded severe psychiatric conditions; therefore, we do not expect that the results are biased due to mood disorder comorbidities. The lack of systematic psychiatric evaluation—such as e.g. the structured clinical interview for DSM-5—does not allow us to check if the data could be confounded by a psychiatric comorbidity (e.g. posttraumatic stress disorder), which is common in FND.2,25
Conclusion
Our findings point towards a multifactorial stress–diathesis model for FND. A flattened CAR might represent a long-term process in direct relation to severity and duration of emotional neglect (state). Reduced subcortical volumes in FND did not relate to HPA axis dysfunction and rather delineate a predisposing biological vulnerability than a disease-related feature, thus potentially representing a trait marker for FND. In line with a stress–diathesis model, phenotypical variations in clinical presentation of symptoms must potentially be attributed to different contributions of a variety of diverse eco-phenotypes (e.g. trauma history) and endo-phenotypes (e.g. biological predisposition or trait markers). However, a causal relationship between HPA axis dysfunction, trauma and brain functional and structural stress adaptation remains to be discovered. Longitudinal data would need to be assessed including the collection of behavioural, neuroendocrine, genetic and neuroimaging data already in early childhood.
Supplementary Material
Acknowledgements
We thank Dr Anita Barbey, Dr Rike Barth, Dr Irena Pjanic and the numerous fellows who helped to recruit patients. We thank the reviewers for their valuable feedback.
Contributor Information
Samantha Weber, Department of Neurology, Psychosomatic Medicine Unit, Inselspital Bern University Hospital, University of Bern, 3012 Bern, Switzerland; Translational Imaging Center (TIC), Swiss Institute for Translational and Entrepreneurial Medicine, 3010 Bern, Switzerland; Graduate School for Cellular and Biomedical Sciences (GCB), University of Bern, 3010 Bern, Switzerland.
Janine Bühler, Department of Neurology, Psychosomatic Medicine Unit, Inselspital Bern University Hospital, University of Bern, 3012 Bern, Switzerland; Translational Imaging Center (TIC), Swiss Institute for Translational and Entrepreneurial Medicine, 3010 Bern, Switzerland; Graduate School for Health Sciences (GHS), University of Bern, 3012 Bern, Switzerland.
Giorgio Vanini, Department of Neurology, Psychosomatic Medicine Unit, Inselspital Bern University Hospital, University of Bern, 3012 Bern, Switzerland.
Serafeim Loukas, Department of Neurology, Psychosomatic Medicine Unit, Inselspital Bern University Hospital, University of Bern, 3012 Bern, Switzerland; Division of Development and Growth, Department of Pediatrics, University of Geneva, 1211 Geneva, Switzerland; Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland.
Rupert Bruckmaier, Veterinary Physiology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland.
Selma Aybek, Department of Neurology, Psychosomatic Medicine Unit, Inselspital Bern University Hospital, University of Bern, 3012 Bern, Switzerland; Translational Imaging Center (TIC), Swiss Institute for Translational and Entrepreneurial Medicine, 3010 Bern, Switzerland.
Funding
This work was supported by the Swiss National Science Foundation (SNF Grant PP00P3_176985 for S.A.).
Competing interests
The authors report no competing interests.
Supplementary material
Supplementary material is available at Brain online.
References
- 1. Bennett K, Diamond C, Hoeritzauer I, et al. A practical review of functional neurological disorder (FND) for the general physician. Clin Med J R Coll Physicians London. 2021;21:28–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Carson A, Lehn A. Epidemiology. In: Handbook of clinical neurology. Vol. 139; 2016:47–60. [DOI] [PubMed] [Google Scholar]
- 3. Hallett M, Aybek S, Dworetzky BA, McWhirter L, Staab JP, Stone J. Functional neurological disorder: New subtypes and shared mechanisms. Lancet Neurol. 2022;21:537–550. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Espay AJ, Aybek S, Carson A, et al. Current concepts in diagnosis and treatment of functional neurological disorders. JAMA Neurol. 2018;75:1132–1141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Aybek S, Perez DL. Diagnosis and management of functional neurological disorder. BMJ. 2022;376:o64. [DOI] [PubMed] [Google Scholar]
- 6. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. American Psychiatric Association; 2013. [Google Scholar]
- 7. LaFaver K. Treatment of functional movement disorders. Neurol Clin. 2020;38:469–480. [DOI] [PubMed] [Google Scholar]
- 8. Drane DL, Fani N, Hallett M, Khalsa SS, Perez DL, Roberts NA. A framework for understanding the pathophysiology of functional neurological disorder. CNS Spectr. 2020;26:555–561. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Ingram RE, Luxton DD. Vulnerability–stress models. In: Development of psychopathology: A vulnerability–stress perspective. SAGE Publications, Inc.; 2005:32–46. [Google Scholar]
- 10. Monroe SM, Cummins LF. Diathesis–stress models. In: The encyclopedia of clinical psychology. John Wiley & Sons, Inc.; 2015:1–6. [Google Scholar]
- 11. Cretton A, Brown RJ, Lafrance WC, Aybek S. What does neuroscience tell us about the conversion model of functional neurological disorders? J Neuropsychiatry Clin Neurosci. 2020;32:24–32. [DOI] [PubMed] [Google Scholar]
- 12. Reuber M, Howlett S, Khan A, Grünewald RA. Non-epileptic seizures and other functional neurological symptoms: Predisposing, precipitating, and perpetuating factors. Psychosomatics. 2007;48:230–238. [DOI] [PubMed] [Google Scholar]
- 13. Perez DL, Nicholson TR, Asadi-Pooya AA, et al. Neuroimaging in functional neurological disorder: State of the field and research agenda. NeuroImage Clin. 2021;30:102623. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Conejero I, Collombier L, Lopez-Castroman J, et al. Association between brain metabolism and clinical course of motor functional neurological disorders. Brain. 2022;145:3264–3273. [DOI] [PubMed] [Google Scholar]
- 15. Keynejad RC, Frodl T, Kanaan R, Pariante C, Reuber M, Nicholson TR. Stress and functional neurological disorders: Mechanistic insights. J Neurol Neurosurg Psychiatry. 2019;90:813–821. [DOI] [PubMed] [Google Scholar]
- 16. Karatzias T, Howard R, Power K, Socherel F, Heath C, Livingstone A. Organic vs. functional neurological disorders: The role of childhood psychological trauma. Child Abuse Negl. 2017;63:1–6. [DOI] [PubMed] [Google Scholar]
- 17. Kanaan RAA, Craig TKJ. Conversion disorder and the trouble with trauma. Psychol Med. 2019;49:1585–1588. [DOI] [PubMed] [Google Scholar]
- 18. Roelofs K, Pasman J. Stress, childhood trauma, and cognitive functions in functional neurologic disorders. In: Hallett M, Stone J, Carson A, eds. Handbook of clinical neurology. Elsevier; 2016:139–155. [DOI] [PubMed] [Google Scholar]
- 19. Roelofs K, Spinhoven P, Sandijck P, Moene FC, Hoogduin KAL. The impact of early trauma and recent life-events on symptom severity in patients with conversion disorder. J Nerv Ment Dis. 2005;193:508–514. [DOI] [PubMed] [Google Scholar]
- 20. Roelofs K, Keijsers GPJ, Hoogduin KAL, Näring GWB, Moene FC. Childhood abuse in patients with conversion disorder. Am J Psychiatry. 2002;159:1908–1913. [DOI] [PubMed] [Google Scholar]
- 21. Ludwig L, Pasman JA, Nicholson T, et al. Stressful life events and maltreatment in conversion (functional neurological) disorder: Systematic review and meta-analysis of case-control studies. Lancet Psychiatry. 2018;5:307–320. [DOI] [PubMed] [Google Scholar]
- 22. Perez DL, Williams B, Matin N, et al. Corticolimbic structural alterations linked to health status and trait anxiety in functional neurological disorder. J Neurol Neurosurg Psychiatry. 2017;88:1052–1059. [DOI] [PubMed] [Google Scholar]
- 23. Aybek S, Nicholson TRJ, Draganski B, et al. Grey matter changes in motor conversion disorder. J Neurol Neurosurg Psychiatry. 2014;85:236–238. [DOI] [PubMed] [Google Scholar]
- 24. Perez DL, Matin N, Williams B, et al. Cortical thickness alterations linked to somatoform and psychological dissociation in functional neurological disorders. Hum Brain Mapp. 2018;39:428–439. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Perez DL, Matin N, Barsky A, et al. Cingulo-insular structural alterations associated with psychogenic symptoms, childhood abuse and PTSD in functional neurological disorders. J Neurol Neurosurg Psychiatry. 2017;88:491–497. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Aybek S, Nicholson TR, Zelaya F, et al. Neural correlates of recall of life events in conversion disorder. JAMA Psychiatry. 2014;71:52–60. [DOI] [PubMed] [Google Scholar]
- 27. Balachandran N, Goodman AM, Allendorfer JB, et al. Relationship between neural responses to stress and mental health symptoms in psychogenic nonepileptic seizures after traumatic brain injury. Epilepsia. 2021;62:107–119. [DOI] [PubMed] [Google Scholar]
- 28. Diez I, Larson AG, Nakhate V, et al. Early-life trauma endophenotypes and brain circuit–gene expression relationships in functional neurological (conversion) disorder. Mol Psychiatry. 2020;26:3817–3828. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Diez I, Ortiz-Terán L, Williams B, et al. Corticolimbic fast-tracking: Enhanced multimodal integration in functional neurological disorder. J Neurol Neurosurg Psychiatry. 2019;90:929–938. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Wheelock MD, Harnett NG, Wood KH, et al. Prefrontal cortex activity is associated with biobehavioral components of the stress response. Front Hum Neurosci. 2016;10:1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Pruessner JC, Dedovic K, Khalili-Mahani N, et al. Deactivation of the limbic system during acute psychosocial stress: Evidence from positron emission tomography and functional magnetic resonance imaging studies. Biol Psychiatry. 2008;63:234–240. [DOI] [PubMed] [Google Scholar]
- 32. Smith SM, Vale WW. The role of the hypothalamic–pituitary–adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci. 2006;8:383–395. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Lupien SJ, Juster RP, Raymond C, Marin MF. The effects of chronic stress on the human brain: From neurotoxicity, to vulnerability, to opportunity. Front Neuroendocrinol. 2018;49:91–105. [DOI] [PubMed] [Google Scholar]
- 34. McEwen BS. Neurobiological and systemic effects of chronic stress. Chronic Stress. 2017;1:247054701769232. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Conrad CD. Chronic stress-induced hippocampal vulnerability: The glucocorticoid vulnerability hypothesis. Rev Neurosci. 2008;19:395–411. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Bakvis P, Roelofs K, Kuyk J, Edelbroek PM, Swinkels WAM, Spinhoven P. Trauma, stress, and preconscious threat processing in patients with psychogenic nonepileptic seizures. Epilepsia. 2009;50:1001–1011. [DOI] [PubMed] [Google Scholar]
- 37. Kozlowska K, Palmer DM, Brown KJ, et al. Reduction of autonomic regulation in children and adolescents with conversion disorders. Psychosom Med. 2015;77:356–370. [DOI] [PubMed] [Google Scholar]
- 38. Kozlowska K, Melkonian D, Spooner CJ, Scher S, Meares R. Cortical arousal in children and adolescents with functional neurological symptoms during the auditory oddball task. NeuroImage Clin. 2017;13:228–236. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Apazoglou K, Mazzola V, Wegrzyk J, Frasca Polara G, Aybek S. Biological and perceived stress in motor functional neurological disorders. Psychoneuroendocrinology. 2017;85:142–150. [DOI] [PubMed] [Google Scholar]
- 40. Bakvis P, Spinhoven P, Giltay EJ, et al. Basal hypercortisolism and trauma in patients with psychogenic nonepileptic seizures. Epilepsia. 2010;51:752–759. [DOI] [PubMed] [Google Scholar]
- 41. Chung J, Mukerji S, Kozlowska K. Cortisol and α-amylase awakening response in children and adolescents with functional neurological (conversion) disorder. Aust New Zeal J Psychiatry. 2022. Online ahead print. [DOI] [PubMed] [Google Scholar]
- 42. Maurer CW, LaFaver K, Ameli R, Toledo R, Hallett M. A biological measure of stress levels in patients with functional movement disorders. Parkinsonism Relat Disord. 2015;21:1072–1075. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Winterdahl M, Miani A, Vercoe MJH, et al. Vulnerability to psychogenic non-epileptic seizures is linked to low neuropeptide Y levels. Stress. 2017;20:589–597. [DOI] [PubMed] [Google Scholar]
- 44. Stalder T, Kirschbaum C, Kudielka BM, et al. Assessment of the cortisol awakening response: Expert consensus guidelines. Psychoneuroendocrinology. 2016;63:414–432. [DOI] [PubMed] [Google Scholar]
- 45. Stone J, Carson A. Functional neurologic disorders. Contin Lifelong Learn Neurol. 2015;21:818–837. [DOI] [PubMed] [Google Scholar]
- 46. Pruessner JC, Wolf OT, Hellhammer DH, et al. Free cortisol levels after awakening: A reliable biological marker for the assessment of adrenocortical activity. Life Sci. 1997;61:2539–2549. [DOI] [PubMed] [Google Scholar]
- 47. Wust S, Wolf J, Hellhammer DH, Federenko I, Schommer N, Kirschbaum C. The cortisol awakening response—Normal values and confounds. Noise Health. 2000;2:79–88. [PubMed] [Google Scholar]
- 48. Nielsen G, Ricciardi L, Meppelink AM, Holt K, Teodoro T, Edwards M. A simplified version of the psychogenic movement disorders rating scale: The simplified functional movement disorders rating scale (S-FMDRS). Mov Disord Clin Pract. 2017;4:710–716. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Spielberger C, Gorsuch R, Lushene R, Vagg P, Jacobs G. Manual for the state–trait anxiety inventory (form:Y1–Y2); 1983. [Google Scholar]
- 50. Beck AT. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561. [DOI] [PubMed] [Google Scholar]
- 51. Shahid A, Wilkinson K, Marcu S, Shapiro CM. Leeds Sleep Evaluation Questionnaire (LSEQ). In: STOP, THAT and one hundred other sleep scales. Springer. 2011:211–213. [Google Scholar]
- 52. Nijenhuis ERS, Van der Hart O, Kruger K. The psychometric characteristics of the Traumatic Experiences Checklist (TEC): First findings among psychiatric outpatients. Clin Psychol Psychother. 2002;9:200–210. [Google Scholar]
- 53. Bernstein DP, Stein JA, Newcomb MDet al. Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse Negl. 2003;27:169–190. [DOI] [PubMed] [Google Scholar]
- 54. Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology. 2003;28:916–931. [DOI] [PubMed] [Google Scholar]
- 55. Fekedulegn DB, Andrew ME, Burchfiel CM, et al. Area under the curve and other summary indicators of repeated waking cortisol measurements. Psychosom Med. 2007;69:651–659. [DOI] [PubMed] [Google Scholar]
- 56. Rolls ET, Huang C-C, Lin C-P, Feng J, Joliot M. Automated anatomical labelling atlas 3. Neuroimage. 2020;206:116189. [DOI] [PubMed] [Google Scholar]
- 57. Krishnan A, Williams LJ, McIntosh AR, Abdi H. Partial least squares (PLS) methods for neuroimaging: A tutorial and review. Neuroimage. 2011;56:455–475. [DOI] [PubMed] [Google Scholar]
- 58. McIntosh AR, Lobaugh NJ. Partial least squares analysis of neuroimaging data: Applications and advances. Neuroimage. 2004;23:S250–S263. [DOI] [PubMed] [Google Scholar]
- 59. Zöller D, Sandini C, Karahanoğlu FI, et al. Large-scale brain network dynamics provide a measure of psychosis and anxiety in 22q11.2 deletion syndrome. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019;4:881–892. [DOI] [PubMed] [Google Scholar]
- 60. Loukas S, Lordier L, Meskaldji DE, et al. Musical memories in newborns: A resting-state functional connectivity study. Hum Brain Mapp. 2022;43:647–664. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Lafrance WC, Baker GA, Duncan R, Goldstein LH, Reuber M. Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: A staged approach: A report from the International League Against Epilepsy Nonepileptic Seizures Task Force. Epilepsia. 2013;54:2005–2018. [DOI] [PubMed] [Google Scholar]
- 62. Stalder T, Evans P, Hucklebridge F, Clow A. Associations between psychosocial state variables and the cortisol awakening response in a single case study. Psychoneuroendocrinology. 2010;35:209–214. [DOI] [PubMed] [Google Scholar]
- 63. Dunn EC, Nishimi K, Powers A, Bradley B. Is developmental timing of trauma exposure associated with depressive and post-traumatic stress disorder symptoms in adulthood? J Psychiatr Res. 2017;84:119–127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Teicher MH, Samson JA. Childhood maltreatment and psychopathology: A case for ecophenotypic variants as clinically and neurobiologically distinct subtypes. Am J Psychiatry. 2013;170:1114–1133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Morsy SK, Aybek S, Carson A, et al. The relationship between types of life events and the onset of functional neurological (conversion) disorder in adults: A systematic review and meta-analysis. Psychol Med. 2021;52:401-–418.. [DOI] [PubMed] [Google Scholar]
- 66. Stone J, Carson A, Aditya H, et al. The role of physical injury in motor and sensory conversion symptoms: A systematic and narrative review. J Psychosom Res. 2009;66:383–390. [DOI] [PubMed] [Google Scholar]
- 67. Dozier M, Peloso E. The role of early stressors in child health and mental health outcomes. Arch Pediatr Adolesc Med. 2006;160:1300. [DOI] [PubMed] [Google Scholar]
- 68. Guilliams TG, Edwards L. Chronic stress and the HPA axis: Clinical assessment and therapeutic considerations. Stand. 2010;9:1–12. [Google Scholar]
- 69. Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology. 2000;25:1–35. [DOI] [PubMed] [Google Scholar]
- 70. Herman JP. Neural control of chronic stress adaptation. Front Behav Neurosci. 2013;7:61. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Yehuda R, Seckl J. Minireview: Stress-related psychiatric disorders with low cortisol levels: A metabolic hypothesis. Endocrinology. 2011;152:4496–4503. [DOI] [PubMed] [Google Scholar]
- 72. Lupien SJ, Evans A, Lord C, et al. Hippocampal volume is as variable in young as in older adults: Implications for the notion of hippocampal atrophy in humans. Neuroimage. 2007;34:479–485. [DOI] [PubMed] [Google Scholar]
- 73. Kozlowska K, Griffiths KR, Foster SL, Linton J, Williams LM, Korgaonkar MS. Grey matter abnormalities in children and adolescents with functional neurological symptom disorder. NeuroImage Clin. 2017;15:306–314. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74. Nicholson TR, Aybek S, Kempton MJ, et al. A structural MRI study of motor conversion disorder: Evidence of reduction in thalamic volume. J Neurol Neurosurg Psychiatry. 2014;85:227–229. [DOI] [PubMed] [Google Scholar]
- 75. Jungilligens J, Popkirov S, Perez DL, Diez I. Linking gene expression patterns and brain morphometry to trauma and symptom severity in patients with functional seizures. Psychiatry Res Neuroimaging. 2022;326:111533. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76. Sojka P, Slovák M, Věchetová G, Jech R, Perez DL, Serranová T. Bridging structural and functional biomarkers in functional movement disorder using network mapping. Brain Behav. 2022;12:1–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77. McLaughlin KA, Colich NL, Rodman AM, Weissman DG. Mechanisms linking childhood trauma exposure and psychopathology: A transdiagnostic model of risk and resilience. BMC Med. 2020;18:1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78. Hornor G. Resilience. J Pediatr Heal Care. 2017;31:384–390. [DOI] [PubMed] [Google Scholar]
- 79. Werner EE. Journeys from childhood to midlife: Risk, resilience, and recovery. Pediatrics. 2004;114:492–492. [DOI] [PubMed] [Google Scholar]
- 80. Taillieu TL, Brownridge DA, Sareen J, Afifi TO. Childhood emotional maltreatment and mental disorders: Results from a nationally representative adult sample from the United States. Child Abuse Negl. 2016;59:1–12. [DOI] [PubMed] [Google Scholar]
- 81. Lippard ETC, Nemeroff CB. The devastating clinical consequences of child abuse and neglect: Increased disease vulnerability and poor treatment response in mood disorders. Am J Psychiatry. 2019;177:20–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82. Gould F, Clarke J, Heim C, Harvey PD, Majer M, Nemeroff CB. The effects of child abuse and neglect on cognitive functioning in adulthood. J Psychiatr Res. 2012;46:500–506. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83. Yeung EW, Davis MC, Ciaramitaro MC. Cortisol profile mediates the relation between childhood neglect and pain and emotional symptoms among patients with fibromyalgia. Ann Behav Med. 2016;50:87–97. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84. Teicher MH, Anderson CM, Ohashi K, Polcari A. Childhood maltreatment: Altered network centrality of cingulate, precuneus, temporal pole and Insula. Biol Psychiatry. 2014;76:297–305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85. Espay AJ, Maloney T, Vannest J, et al. Impaired emotion processing in functional (psychogenic) tremor: A functional magnetic resonance imaging study. NeuroImage Clin. 2018;17:179–187. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86. Aybek S, Nicholson TR, O’Daly O, Zelaya F, Kanaan RA, David AS. Emotion–motion interactions in conversion disorder: An fMRI study. PLoS One. 2015;10:1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87. Blakemore RL, Sinanaj I, Galli S, Aybek S, Vuilleumier P. Aversive stimuli exacerbate defensive motor behaviour in motor conversion disorder. Neuropsychologia. 2016;93:229–241. [DOI] [PubMed] [Google Scholar]
- 88. Womersley JS, Hemmings SMJ, Ziegler C, et al. Childhood emotional neglect and oxytocin receptor variants: Association with limbic brain volumes. World J Biol Psychiatry. 2020;21:513–528. [DOI] [PubMed] [Google Scholar]
- 89. Krol KM, Puglia MH, Morris JP, Connelly JJ, Grossmann T. Epigenetic modification of the oxytocin receptor gene is associated with emotion processing in the infant brain. Dev Cogn Neurosci. 2019;37:100648. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90. Apazoglou K, Adouan W, Aubry JM, Dayer A, Aybek S. Increased methylation of the oxytocin receptor gene in motor functional neurological disorder: A preliminary study. J Neurol Neurosurg Psychiatry. 2018;89:552–554. [DOI] [PubMed] [Google Scholar]
- 91. Spagnolo PA, Norato G, Maurer CW, et al. Effects of TPH2 gene variation and childhood trauma on the clinical and circuit-level phenotype of functional movement disorders. J Neurol Neurosurg Psychiatry. 2020;91:814–821. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92. Adam EK, Kumari M. Assessing salivary cortisol in large-scale, epidemiological research. Psychoneuroendocrinology. 2009;34:1423–1436. [DOI] [PubMed] [Google Scholar]
- 93. Elder GJ, Ellis JG, Barclay NL, Wetherell MA. Assessing the daily stability of the cortisol awakening response in a controlled environment. BMC Psychol. 2016;4:3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94. Hellhammer DH, Wüst S, Kudielka BM. Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology. 2009;34:163–171. [DOI] [PubMed] [Google Scholar]
- 95. Brown G, Harris T. Life events and illness. Guilford Press; 1989. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data are not publicly available due to restrictions demanded by the administering institution to guarantee the privacy of the participants. The data can be shared upon request.






